TARCC Research Publications PDF Print E-mail

Supported by the contributions of more than two dozen researchers at six leading Texas medical research institutions, the Texas Alzheimer's Research and Care Consortium (TARCC) conducts advanced research on the genetic, biomarker and neuropsychological aspects of Alzheimer's disease (AD) in an attempt to achieve breakthroughs in detection, treatment, slowing progression and prevention of AD.

Research Publications Access all publications authored by TARCC researchers on PubMed.

Read the latest publications from the Texas Alzheimer's Research and Care Consortium. 

PUBLICATIONS

    1. O’Bryant SE, Johnson L, Reisch J, Edwards M, Hall J, Barber R, Devous M, Royall D, Singh M. 2013. Risk factors for mild cognitive impairment among Mexican Americans. Alz Dement; In Press. PMID: 23643456.
    2. O’Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, Edwards M, Grammas P, Wilhelmsen K, Doody R, Diaz-Arrastia R, for the Texas Alzheimer’s Research Consortium. 2013. Molecular Neuropsychology: Creation of test-specific blood biomarker algorithms. Dement Geriat Cog Disord; In Press.
    3. Ferrari R, Dawoodi S, Raju M, Thumma A, Hynan LS, Massumi SH, Reisch JS, O’Bryant S, Jenkins M, Barber R Momeni P. 2013. Androgen receptor gene and gender specific Alzheimer's disease. Neurobiol Aging; 34(8): 2077.e19-20. PMID: 23545426.
    4. Hall, JR, Wiechmann A, Johnson LA, Edwards M, Barber RC, Winter AS, Singh M, Obryant SE. 2013. Biomarkers of vascular risk, systemic inflammation and microvascular pathology and neuropsychiatric symptoms in Alzheimer’s disease. J Alz Dis; 35:363-371.
    5. O’Bryant SE, Xiao G, Edwards M, Devous M, Barber R, Simpkins J for the Texas Alzheimer’s Research and Care Consortium. 2013. Biomarkers of Alzheimer’s disease among Mexican Americans. J Alz Dis; 34(4): 841-849.
    6. O’Bryant SE, Johnson L, Balldin V, Edwards M, Barber R, Williams B, Devous M, Sushing B, Knebl J, Hall J. 2013.  Characterization of Mexican Americans with mild cognitive impairment and Alzheimer’s disease. J Alz Dis; 33:373-379.
    7. O'Bryant SE, Johnson L, Edwards M, Soares H, Devous MD, Ross S, Rohlfing G, Hall J; Texas Alzheimer’s Research & Care Consortium. 2013. The link between C-reactive protein and Alzheimer's disease among Mexican Americans. J Alz Dis; 2013;34(3):701-6. doi: 10.3233/JAD-122071
    8. Pavlik V, Massman P, Barber R, Doody R, for the Texas Alzheimer’s Research and Care Consortium (TARCC). 2013. Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer’s disease cases and normal controls. J Alz Dis 34(2):449-456. PMID: 23241558.
    9. Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC, Momeni P. 2012. Implication of common and disease specific variants in CLU, CR1 and PICALM. Neurobiol Aging; 33:1846.e7-1846.e18.
    10. Barber RC. 2012. The genetics of Alzheimer’s disease. Scientifica; vol. 2012, Article ID 246210, 14 pages. doi:10.6064/2012/246210
    11. Hall JR, Johnson L, Wiechmann A, Barber RC, O’Bryant SE. 2012. Depressive symptom endorsement among Alzheimer’s disease, vascular dementia and mild cognitive impairment. J Med Psych; 1:32-37.
    12. Royall DR, Palmer RF, O'Bryant SE. 2012. Validation of a latent variable representing the dementing process. J Alz Dis; 30(3):639-49. doi: 10.3233/JAD-2012-120055.
    13. Barber RC, Edwards MI, Xiao G, Huebinger RM, Diaz-Arrastia R, Wilhelmsen KC, Hall JR, O’Bryant SE for the Texas Alzheimer’s Research and Care Consortium. 2012. Serum granulocyte colony stimulating factor and Alzheimer’s disease. Dement Geriat Cog Disord Extra; 2:353-360.
    14. Balldin VH, Hall JR, Barber RC, Hynan L, Diaz-Arrastia R, O'Bryant S. 2012. The relation between inflammation and neuropsychological test performance. Int J Alz Dis; vol. 2012, Article ID 703871, 6 pages. doi:10.1155/2012/703871.
    15. Hall JR, Johnson LA, Barber RC, Vo HT, Winter AS, O’Bryant SE. 2012. Biomarkers of basic activities of daily living in Alzheimer's disease. J Alz Dis; 31:429-437.
    16. Hall J, Vo H, Johnson L, Barber R, Winter S, O’Bryant S. 2012. Biomarkers and depressive symptoms in older women with and without cognitive impairment. J Behav Brain Sci; 2:276-281
    17. Warren MW, Hynan LS, Weiner MF, Doody R, Rountree S, Capriles V, Ballantyne C, Darby E, Dawson T, Hittle A, Khaleeg A, O’Bryant SE, Grammas P, Williams B, Wu CK, Zhang Y, Schrimsher G, Dentino A, Momeni P, Hill L, Fairchild T, Knebl J, Barber R, Mains D, Alvarez L, Aams P, Rosenberg R, Reisch J, Huebinger R, Svetlik D, Murray JSM, Sears T, Royall D, Hazuda H, Palmer R, Polk M. 2012. Lipids and adipokines as risk factors for Alzheimer’s disease. J Alz Dis; 29:151-157.
    18. Hall JR, O’Bryant SE, Johnson LA, Barber RC. 2011. Depression and brain-derived neurotrophic factor levels in Alzheimer’s disease. Neurosci Med; 2:43-47.
    19. Hall JR, Vo HT, Johnson L, Barber RC, O'Bryant SE. 2011. The link between cognitive measures and ADL and IADL functioning in mild Alzheimer's: What has gender got to do with it? Int J Alz Dis; vol. 2011:276734.
    20. Barber RC. 2011. Inflammatory signaling in Alzheimer disease and depression. Clev Clinic J Med; 78 Suppl 1:S47-9. PMID: 21972331
    21. Hall J, Vo H, Johnson L, Barber R, Winter S, O'Bryant S. 2011. Biomarkers and depressive symptoms in cognitively intact and Alzheimer's disease elderly males. Neurosci Med; 2:63-68.
    22. Hall JR, O'Bryant SE, Johnson LA, Barber RC. 2011. Depressive symptom clusters and neuropsychological performance in mild Alzheimer's and cognitively intact elderly. Depress Res Treat; 2011:396958. PMID: 21904674
    23. O’Bryant S, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, Doody R, Fairchild T, Adams P, Wilhelmsen K, Diaz-Arrastia R. 2011. A blood-based algorithm for the detection of Alzheimer’s disease. Dem Rel Cog Dis; 32:55-62. PMID: 21865746
    24. Hobson VL, Hall JR, Harvey M, Cullum CM, Lacritz L, Massman PJ, Waring SC, O'Bryant SE. 2011. An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population. Int J Geriatr Psychiatry; 26:351-355. PMID:20690129
    25. O’Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, Waring S, Diaz-Arrastia R. for the Texas Alzheimer’s Research Consortium. 2010. A serum protein-based algorithm for the detection of Alzheimer’s disease. Arch Neuro;l 67:1077-1081. PMID: 20837851
    26. O’Bryant SE, Hobson VL, Hall JR, Barber RC, Zhang S, Johnson L, Diaz-Arrastia R, for the Texas Alzheimer’s Research Consortium. 2010. Serum brain-derived neurotrophic factor (BDNF) levels are specifically associated with memory performance among Alzheimer’s disease cases. Dement Geriat Cog Disord; 31:31-36. PMID: 21135555
    27. O'Bryant SE, Waring SC, Hobson V, Hall JR, Moore CB, Bottiglieri T, Massman P, Diaz-Arrastia R. 2010. Decreased C-reactive protein levels in Alzheimer disease. J Geriat Psych Neurol; 23:49-53. PMID: 19933496
    28. Barber RC. 2010. Biomarkers for Early Detection of Alzheimer’s Disease. In: Supplemental Volume on Alzheimer’s Disease. JW Simpkins, B Balin, B Wood Eds, Journal of the American Osteopathic Association, (Chicago, IL). 110 (9): Supplement 8 S10-S15. PMID: 20926738
    29. O'Bryant SE, Hobson V, Hall JR, Waring SC, Chan W, Massman P, Lacritz L, Cullum CM, Diaz-Arrastia R. 2009. Brain-derived neurotrophic factor (BDNF) in Alzheimer’s disease. A project of the Texas Alzheimer’s Research Consortium (TARC). J Alz Dis; 17: 337-341. PMID: 19363274
    30. Hobson VL, O’Bryant SE, Hall J, Cullum M, Lacritz L, Massman P, Waring SC for the TARC. 2008. Serum BDNF and Alzheimer’s disease severity: An investigation by the Texas Alzheimer’s Research Consortium. Arch Clin Neuropsych; 23:674.
    31. O’Bryant SE, Hobson VL, Hall J, Cullum M, Lacritz L, Massman P, Waring SC, Schiffer R for  the TARC. 2008. Peripheral inflammation and neuropsychological test performance: An investigation by the Texas Alzheimer’s Research Consortium. Arch Clin Neuropsych; 23:673.
    32. O’Bryant SE, Waring SC, Cullum CM, Hall JR, Lacritz LH, Massman PJ, Doody RS, Lupo P, Reisch J and the TARC. 2008. Staging dementia severity with CDR Sum of Box Scores: An investigation by the Texas Alzheimer’s Research Consortium. Arch Neurol; 65:1091-1095.
    33. O’Bryant SE, Grammas P. 2008. A case for the creation of a biomarker-based algorithm for the detection of Alzheimer’s disease. J Tex Pub Hlth Assn; 63:14-17.
    34. Waring SC, O'Bryant SE, Reisch J, Diaz-Arrastia R, Knebl J, Doody RS for the TARC. 2008. The Texas Alzheimer’s Research Consortium longitudinal research cohort:  Study design and baseline characteristics. J Tex Pub Hlth Assn; 63:9-13.
    35. Hall JR, Schiffer RB, O'Bryant SE. 2008. Depression and Alzheimer’s disease. J Tex Pub Hlth Assn; 63:25-29.
    36. O'Bryant SE, Hall JR, Waring SC, Humphreys JD, Hobson V, Schiffer RB. 2008. The relationship between cardiovascular disease and AD. J Tex Pub Hlth Assn; 63:22-24.
    37. Rustfeld LO, Pavlik VN, Doody RS. 2008. Hyperinsulinemia, type-2 diabetes mellitus and cognitive decline. J Tex Pub Hlth Assn; 63:17-22.
    38. Fairchild T. 2008. Economic impact of AD in Texas. J Tex Pub Hlth Assn; 63:5-8.



      MANUSCRIPTS


      TARCC AUTHORS

      TITLE

      RESEARCH JOURNAL

      Royall DR, Palmer RF, O’Bryant SEValidation of a latent variable representing the dementing processJournal of Alzheimer’s Disease 2012; In Press
      Balldin VH, Hall JR, Barber RC, Hynan L, Diaz-Arrastia R, O'Bryant SThe relation between inflammation and neuropsychological test performanceJ Neuroinflamm 2012; In Press
      Hall J, Vo H, Johnson L, Barber R, Winter S, O’Bryant SBiomarkers and depressive symptoms in older women with and without cognitive impairmentJ Behav Brain Sci 2012; In Press
      Ferrari R, Moreno JH, Minhajuddin AT, O'Bryant SE, Reisch JS, Barber RC, Momeni PImplication of common and disease specific variants in CLU, CR1 and PICALMNeurobiol Aging 2012; In Press.
      Hall, JR, O’Bryant, SE, Johnson, LA, Barber, RCDepression and brain-derived neurotrophic factor levels in Alzheimer’s diseaseNeurosci Med 2012; In Press
      Hall JR, Vo HT, Johnson L, Barber RC, O’Bryant SE. 2011.The link between cognitive measures and ADL and IADL functioning in mild Alzheimer’s: What has gender got to do with it?International Journal of Alzheimer’s Disease 2011; 2011:276734
      Barber RCInflammatory signaling in Alzheimer disease and depressionClev Clinic J Med 2011; 78 Suppl 1:S47-9
      Hall J, Vo H, Johnson L, Barber R, Winter S, O’Bryant SBiomarkers and depressive symptoms in cognitively intact and Alzheimer's disease elderly malesNeurosci Med 2011; 2:63-68
      Hall JR, O'Bryant SE, Johnson LA, Barber RCDepressive symptom clusters and neuropsychological performance in mild Alzheimer's and cognitively intact elderlyDepression Research and Treatment 2001; 2011:396958
      O’Bryant SE, Xiao, Barber R, Huebinger R, Wilhelmsen K, Edwards M, Graff-Radford N, Doody R, Diaz-Arrastia R, for the Texas Alzheimer’s Research & Care Consortium, for the Alzheimer’s Disease Neuroimaging InitiativeA blood-based screening tool for Alzheimer’s disease that spans serum and plasma: Findings from TARC and ADNIPLoS ONE 2011; 6(12)e28092
      O’Bryant S, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, Doody R, Fairchild T, Adams P, Wilhelmsen K, Diaz-Arrastia RA blood-based algorithm for the detection of Alzheimer’s diseaseDementia and Related Cognitive Disorders 2011; 32:55-62
      Hobson VL, Hall JR, Harvey M, Cullum CM, Lacritz L, Massman PJ, Waring SC, O'Bryant SEAn examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population

      International Journal of Geriatric Psychiatry 2011; 26:351-355.

      Sid E. O’Bryant, Guanghua Xiao, Robert Barber, Stephen Waring, Joan Reisch, Rachelle Doody, Thomas Fairchild, Perrie Adams, & Ramon Diaz-Arrastia for the Texas Alzheimer’s Research Consortium.A Serum Protein-Based Diagnostic Algorithm for the Detection of Alzheimer’s Disease

      (Appendix 1)
      Archives of Neurology 2010, 67(9):1077-1081
      O’Bryant SE, Hobson VL, Hall JR, Barber RC, Zhang S, Johnson L, Diaz-Arrastia R, for the Texas Alzheimer’s Research Consortium.Serum brain-derived neurotrophic factor (BDNF) levels are specifically associated with memory performance among Alzheimer’s disease casesDementia and Geriatric Cognitive Disorders 2010; 31:31-36
      O’Bryant, SE, Hobson, V, Hall, J, Massman, P, Diaz-Arrastia.Decreased CRP in Alzheimer’s DiseaseJournal of Geriatric Psychiatry and Neurology 2010, 23:49-53.
      Barber RCBiomarkers for Early Detection of Alzheimer’s DiseaseJournal of the American Osteopathic Association, (Chicago, IL) 2010; 110 (9): Supplement 8 S10-S15
      O’Bryant, SE, Hobson, V, Hall, J, Lacritz, L, Massman, P, Cullum, M, Diaz-Arrastia, R.Brain-derived neurotropic factor (BDNF) in Alzheimer’s disease. A project of the Texas Alzheimer’s Research Consortium (TARC)
      Journal of Alzheimer’s Disease 2009; 17:1051-1055.
      Hobson VL, O’Bryant SE, Hall J, Cullum M, Lacritz L, Massman P, Waring SC for the Texas Alzheimer’s Research ConsortiumSerum BDNF and Alzheimer’s Disease Severity: An investigation by the Texas Alzheimer’s Disease Research Consortium

      Archives of Clinical Neuropsychology 2008; 23:674.

      O’Bryant SE, Hobson VL, Hall J, Cullum M, Lacritz L, Massman P, Waring SC, Schiffer R for the Texas Alzheimer’s Research ConsortiumPeripheral Inflammation and Neuropsychological Test Performance: An Investigation by the Texas Alzheimer’s Disease Research Consortium

      Archives of Clinical Neuropsychology 2008; 23:673.

      O’Bryant SE, Waring SC, Cullum CM, Hall JR, Lacritz LH, Massman PJ, Doody RS, Lupo P, Reisch J and the Texas Alzheimer’s Research ConsortiumStaging Dementia Severity with CDR Sum of Box Scores: An investigation by the Texas Alzheimer’s Disease Research Consortium

      Archives of Neurology 2008; 65:1091-1095.

      O’Bryant SE, Grammas P.A Case for the Creation of a Biomarker-Based Algorithm for the Detection of Alzheimer’s DiseaseJournal of the Texas Public Health Association 2008; 63:14-17.
      Waring SC, O'Bryant SE, Reisch J, Diaz-Arrastia R, Knebl J, Doody RS for the Texas Alzheimer’s Research ConsortiumThe Texas Alzheimer’s Research Consortium Longitudinal Research Cohort: Study Design and Baseline Characteristics

      Journal of the Texas Public Health Association 2008; 63:9-13.

      Hall JR, Schiffer RB, O'Bryant SE.Depression and Alzheimer’s Disease

      Journal of the Texas Public Health Association 2008; 63:25-29.

      O'Bryant SE, Hall JR, Waring SC, Humphreys JD, Hobson V, Schiffer RB.The Relationship Between Cardiovascular Disease and ADJournal of the Texas Public Health Association 2008; 63:22-24.
      Rustfeld LO, Pavlik VN, Doody RS.Hyperinsulinemia Type-2 Diabetes Mellitus and Cognitive DeclineJournal of the Texas Public Health Association 2008; 63:17-22.
      Fairchild T.Economic impact of AD in Texas
      Journal of the Texas Public Health Association 2008; 63:5-8.
      O’Bryant SE, Waring SC, Cullum CM, Hall JR, Lacritz LH, Massman PJ, Doody RS, Lupo P, Reisch J, and the Texas Alzheimer’s Research ConsortiumStaging Dementia Severity with CDR Sum of Box Scores: An investigation by the Texas Alzheimer’s Disease Research Consortium

      Archives of Clinical Neuropsychology 2007; 22:822.



       





      Texas Alzheimer’s Research and Care Consortium

      TARCC Promotional Video
      Watch the TARCC Video Here

      Alzheimer's Facts

      The national Alzheimer's Association projects that about 470,000 Texans will have Alzheimer's disease by 2025.